Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Ruggieri

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 27, 2013
Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx miceRoberto Tamma, Tiziana Annese, Roberta F Capogrosso, et al.
Oncotarget|April 19, 2017
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphomaSimona Ruggieri, Roberto Tamma, Nicoletta Resta, et al.
Annals of Hematology|March 29, 2018
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myelomaVanessa Desantis, Maria Antonia Frassanito, Roberto Tamma, et al.
Experimental Cell Research|March 27, 2016
Isolation and characterization of neural stem cells from dystrophic mdx mouseTiziana Annese, Patrizia Corsi, Simona Ruggieri, et al.
Cancer Letters|July 20, 2014
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiformeSimona Ruggieri, Roberto Tamma, Andrea Marzullo, et al.
Stem Cell Research & Therapy|January 17, 2019
DP71 and SERCA2 alteration in human neurons of a Duchenne muscular dystrophy patientSimona Ruggieri, Luigi Viggiano, Tiziana Annese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2013
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myelomaMichele Moschetta, Antonio Basile, Arianna Ferrucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2013
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic targetRoberto Ria, Ivana Catacchio, Simona Berardi, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 27, 2013
Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx miceRoberto Tamma, Tiziana Annese, Roberta F Capogrosso, et al.
Oncotarget|April 19, 2017
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphomaSimona Ruggieri, Roberto Tamma, Nicoletta Resta, et al.
Annals of Hematology|March 29, 2018
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myelomaVanessa Desantis, Maria Antonia Frassanito, Roberto Tamma, et al.
Experimental Cell Research|March 27, 2016
Isolation and characterization of neural stem cells from dystrophic mdx mouseTiziana Annese, Patrizia Corsi, Simona Ruggieri, et al.
Cancer Letters|July 20, 2014
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiformeSimona Ruggieri, Roberto Tamma, Andrea Marzullo, et al.
Stem Cell Research & Therapy|January 17, 2019
DP71 and SERCA2 alteration in human neurons of a Duchenne muscular dystrophy patientSimona Ruggieri, Luigi Viggiano, Tiziana Annese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2013
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myelomaMichele Moschetta, Antonio Basile, Arianna Ferrucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2013
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic targetRoberto Ria, Ivana Catacchio, Simona Berardi, et al.
Pageof 5